ABCELLERA BIOLOGICS (8QQ) — Cash Flow Quality Index
ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Quality Index of 1.75x as of December 2022. Operating cash flow of €277.36 Million exceeds net income of €158.52 Million, indicating high earnings quality where cash backs reported profits. Explore ABCELLERA BIOLOGICS long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ABCELLERA BIOLOGICS Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for ABCELLERA BIOLOGICS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ABCELLERA BIOLOGICS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year earnings quality comparison for ABCELLERA BIOLOGICS. For live market cap and the full company financial profile, see 8QQ market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.75x | €277.36 Million | €158.52 Million | ▲ +9.8% |
| 2021 | 1.59x | €244.58 Million | €153.46 Million | — |